WHY IT MATTERS
BIOBANKING SERVICES
The gap between what we know and what we do is one of the largest remediable sources of preventable harm in medicine.
~17 years
The frequently cited estimate for the lag between research evidence and routine clinical practice
(Balas & Boren 2000)
A Fraction
Of original discoveries ever reach day-to-day care at all — and the lag itself resist a single robust number
(Morris, Wooding, & Grant 2011)
Wide
Unexplained geographic and between-site variation in practice and outcomes for identical conditions
(Dartmouth Atlas Tradition)
Those numbers describe a translational failure, not a knowledge failure. We generate an enormous amount of evidence; we are slow and uneven at putting it to work. A Learning Health System is the organizational answer to that problem — infrastructure that shortens the distance between a finding and a change in care, and then measures whether the change helped.
Five reasons the model earns its keep
- Speed. Evidence that takes years to diffuse can, in a functioning LHS, move into an order set or pathway in weeks — with the effect measured rather than assumed.
- Relevance. Classical trials answer questions about carefully selected populations. Real-world data answers questions about the patients actually in front of us, including rural, Native American, Hispanic/Latino, and border communities that are under-represented in registration trials.
- Efficiency. When learning is embedded in operations, evidence generation becomes a by-product of care rather than a separate, expensively duplicated enterprise.
- Equity. Systematic self-study surfaces disparities that averages hide — who is getting the guideline-concordant care and who is not.
- Accountability. Health systems are increasingly asked to demonstrate value. An LHS produces the evidence that a change actually improved outcomes, and detects unintended consequences early.
What each side gains
| For the health system | For the research community |
|---|---|
| Rigorous, timely evaluation of QI and standardization initiatives | Access to real-world data and to the populations that most need answers |
| Early detection of unintended consequences and site-level variation | A route for findings to reach practice instead of stopping at publication |
| Analytic capacity that operational teams rarely have bandwidth to build | Pragmatic trial and embedded-research opportunities at scale |
| A pipeline of clinically fluent data scientists and informaticians | Questions shaped by the people who will have to act on the answers |
| External funding that supports internal quality goals | A durable partnership rather than a one-off data request |
